Get the Stockscreener App
293.99
3.71%
10.51
Pre-market:
294.16
0.17
+0.06%
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $293.99, with a volume of 2.41M.
It is up +3.71% in the last 24 hours and down -15.87% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$283.48
Open:
$283.72
24h Volume:
2.41M
Relative Volume:
1.06
Market Cap:
$66.20B
Revenue:
$189.25B
Net Income/Loss:
$5.36B
P/E Ratio:
12.51
EPS:
23.5
Net Cash Flow:
$5.34B
1W Performance:
+7.04%
1M Performance:
-15.87%
6M Performance:
-24.89%
1Y Performance:
-44.16%
1-Day Range:
$283.72
$295.18
1-Week Range:
$273.71
$295.18
52-Week Range:
$273.71
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
293.99 | 62.22B | 189.25B | 5.36B | 5.34B | 23.50 |
|
UNH
Unitedhealth Group Inc
|
250.89 | 222.96B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.54 | 80.56B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
274.90 | 72.06B | 260.93B | 5.02B | 3.94B | 18.32 |
|
HUM
Humana Inc
|
266.68 | 30.86B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Bronstein, Gewirtz & Grossman, LLC Encourages Elevance Health, Inc. (ELV) Investors to Inquire about Securities Investigation - ACCESS Newswire
Baird Reduces PT on Elevance Health (ELV) Stock, Maintains Neutral - MSN
Mizuho Securities Maintains Buy Rating on Elevance Health with $342 Price Target - AInvest
Elevance Health (ELV) Nosedives 12% on Disappointing Q2 - MSN
UBS Affirms Elevance Health’s (ELV) ‘Buy’ Rating on Earning Stability and Growth Prospects - Insider Monkey
Baird Lowers Elevance Health Price Target to $297, Maintains Neutral Rating. - AInvest
Iowa House panel dismisses ethics complaint over lobbying on PBM bill - The Des Moines Register
Meta Platforms and Elevance Health have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bear of the Day: Elevance Health (ELV) - The Globe and Mail
Bear Of The Day: Elevance Health (ELV) - Barchart.com
Is it the right time to buy Elevance Health Inc. stockFree Stock Market Trend Analysis - Jammu Links News
When is Elevance Health Inc. stock expected to show significant growthDynamic investment opportunities - Jammu Links News
How strong is Elevance Health Inc. company’s balance sheetCapitalize on market opportunities with confidence - Jammu Links News
Should I hold or sell Elevance Health Inc. stock in 2025Proven strategies for superior portfolio growth - Jammu Links News
What are Elevance Health Inc. company’s key revenue driversAchieve consistent double-digit growth - Jammu Links News
Why is Elevance Health Inc. stock attracting strong analyst attentionInvest confidently with real-time data - Jammu Links News
What are analysts’ price targets for Elevance Health Inc. in the next 12 monthsUnlock daily market insights for better decisions - Jammu Links News
Insider Activity at Elevance Health: A Tale of Confidence and Cautious Diversification - AInvest
Elevance Health Insiders Sell US$6.7m Of Stock, Possibly Signalling Caution - Yahoo Finance
Trapped Investors in Elevance Health Inc. Await Breakout SignalMarket Entry and Exit Point Tips From Traders - metal.it
Elevance Health stock hits 52-week low at $274.33 - Investing.com Australia
Elevance Health stock hits 52-week low at $274.33 By Investing.com - Investing.com India
UnitedHealth replaces CFO Rex in another management shake-up - Reuters
Is Elevance Health Inc. stock overvalued or undervaluedSwing Trade Target Finder With Low Risk - Jammu Links News
Peter Lynch's Top Health Care Stocks Based on Validea: Elevance Health and UFP Technologies - AInvest
Why Elevance Health Inc. stock attracts strong analyst attentionSwing Setup With Technical Confirmation Explained - metal.it
Positive Sentiment Still Eludes Elevance Health, Inc. (NYSE:ELV) Following 25% Share Price Slump - simplywall.st
Does Elevance Health (NYSE:ELV) Have A Healthy Balance Sheet? - Yahoo Finance
Elevance Health Board Appoints Steve Collis As Director - citybiz
Momentum Screeners Rank Elevance Health Inc. in Top 5 TodayRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs - MSN
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - The Globe and Mail
Medicare Advantage in 2025: Enrollment Update and Key Trends - KFF
Elevance Health (ELV) Receives Buy Rating from UBS with Optimistic EPS Forecast - GuruFocus
Elevance Health, Inc: A Deeply Undervalued Long-Term OpportunityF.A.S.T. GraphsCommentaries - Advisor Perspectives
Is Elevance Health Inc. a growth stock or a value stockGet daily updates on promising stocks - jammulinksnews.com
What makes Elevance Health Inc. stock price move sharplyFree Stock Review For Consistent Profits - jammulinksnews.com
How many analysts rate Elevance Health Inc. as a “Buy”Unlock real-time trading signals for gains - jammulinksnews.com
What is the dividend policy of Elevance Health Inc. stockMarket-crushing profits - Jammu Links News
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Kilgore News Herald
Indiana Chamber Ends Partnership With Anthem, Cites Negotiation Breakdown - InkFreeNews.com
Centene's First Quarterly Loss In 13 Years Sends Shares Crashing - Benzinga
Elevance Health Inc. Stock Analysis and ForecastHigh-yield trading alerts - PrintWeekIndia
Elevance Health (ELV) Analyst Rating Update: Price Target Adjusted | ELV Stock News - GuruFocus
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):